PT Itama Ranoraya Tbk 2024 AR2

The report highlights PT Itama Ranoraya Tbk's performance in 2024, where the company recorded a significant 40.4% increase in total sales to IDR 977.5 billion and a net profit surge of 924.6% to IDR 53.3 billion. The company expanded its business into tuberculosis and non-communicable disease treatments, strengthening its healthcare distribution network across Indonesia. In sustainability, the company actively conducted free health screenings, supported blood donation campaigns, and implemented energy and water-saving initiatives. Additionally, the company successfully managed hazardous waste from shipping defects and reduced paper consumption to support environmental conservation.

Company: PT Itama Ranoraya Tbk

Sector: Health Care

Country: Indonesia

Year: 2024

Type: AR2

Pages: 323

Back to company

PT Itama Ranoraya Tbk

PT Itama Ranoraya Tbk 2024 Annual Report

Data Services

Need sustainability data at scale?

Request a quote

Annual Report

The report highlights PT Itama Ranoraya Tbk's performance in 2024, where the company recorded a significant 40.4% increase in total sales to IDR 977.5 billion and a net profit surge of 924.6% to IDR 53.3 billion. The company expanded its business into tuberculosis and non-communicable disease treatments, strengthening its healthcare distribution network across Indonesia. In sustainability, the company actively conducted free health screenings, supported blood donation campaigns, and implemented energy and water-saving initiatives. Additionally, the company successfully managed hazardous waste from shipping defects and reduced paper consumption to support environmental conservation.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Sign InCreate Account

Document Details

Report Year

2024

Reporting Period

Jan 1, 2024 - Dec 31, 2024

Fiscal Year

2024

Type

Annual Report with Sustainability Disclosures

Language

English, Indonesian

Pages

 

File Size

 

Standards & Assurance

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Scope 3:

Water Consumption

Total Waste

Women on Board

Workplace Fatalities

Employees